000 01497 a2200421 4500
005 20250514170757.0
264 0 _c20040409
008 200404s 0 0 eng d
022 _a0095-1137
024 7 _a10.1128/JCM.42.2.563-569.2004
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aElbeik, Tarek
245 0 0 _aMulticenter evaluation of the performance characteristics of the bayer VERSANT HCV RNA 3.0 assay (bDNA).
_h[electronic resource]
260 _bJournal of clinical microbiology
_cFeb 2004
300 _a563-9 p.
_bdigital
500 _aPublication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650 0 4 _aBranched DNA Signal Amplification Assay
_xmethods
650 0 4 _aHepacivirus
_xclassification
650 0 4 _aHepatitis C
_xblood
650 0 4 _aHumans
650 0 4 _aRNA, Viral
_xblood
650 0 4 _aReagent Kits, Diagnostic
650 0 4 _aReproducibility of Results
650 0 4 _aSensitivity and Specificity
650 0 4 _aSpecimen Handling
700 1 _aSurtihadi, Johan
700 1 _aDestree, Mark
700 1 _aGorlin, Jed
700 1 _aHolodniy, Mark
700 1 _aJortani, Saeed A
700 1 _aKuramoto, Ken
700 1 _aNg, Valerie
700 1 _aValdes, Roland
700 1 _aValsamakis, Alexandra
700 1 _aTerrault, Norah A
773 0 _tJournal of clinical microbiology
_gvol. 42
_gno. 2
_gp. 563-9
856 4 0 _uhttps://doi.org/10.1128/JCM.42.2.563-569.2004
_zAvailable from publisher's website
999 _c14490356
_d14490356